2D12

ICD-11 MMS 2026-01

Malignant neoplasms of other endocrine glands or related structures

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Excludes

  • 2C10 – Malignant neoplasm of pancreas
  • 2C27 – Malignant neoplasms of thymus
  • 2C73 – Malignant neoplasms of ovary
  • 2C80 – Malignant neoplasms of testis
  • 2D10 – Malignant neoplasms of thyroid gland
  • 2D11 – Malignant neoplasms of adrenal gland
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms

Exclusions from above levels

  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Child codes

  • 2D12.0 – Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type
  • 2D12.1 – Adenocarcinoma of other endocrine glands or related structures
  • 2D12.Y – Other specified malignant neoplasms of other endocrine glands or related structures
  • 2D12.Z – Malignant neoplasms of other endocrine glands or related structures, unspecified

Sibling codes

  • 2D10 – Malignant neoplasms of thyroid gland
  • 2D11 – Malignant neoplasms of adrenal gland
  • 2D1Z – Malignant neoplasms of endocrine glands, unspecified

Foundation entity

Malignant neoplasms of other endocrine glands or related structures – http://id.who.int/icd/entity/202249350

Allowed postcoordination axes

Part of: 02: Neoplasms